These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25364893)

  • 1. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy.
    Tsujimoto T; Yamamoto-Honda R
    Ann Intern Med; 2014 Nov; 161(9):678-9. PubMed ID: 25364893
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.
    Gudzune KA; Monroe AK; Sharma R; Ranasinghe PD; Chelladurai Y; Robinson KA
    Ann Intern Med; 2014 Apr; 160(7):468-76. PubMed ID: 24514899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins: established indications and controversial subgroups.
    Jukema JW; Bergheanu SC
    Heart; 2008 Dec; 94(12):1656-62. PubMed ID: 19011141
    [No Abstract]   [Full Text] [Related]  

  • 7. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 8. [HMA CoA reductase inhibitors].
    Kostner GM
    Wien Med Wochenschr; 1999; 149(5-6):109-10. PubMed ID: 10408000
    [No Abstract]   [Full Text] [Related]  

  • 9. 2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.
    Myerson M; Rosenson RS
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):203-4. PubMed ID: 24610170
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
    Radermecker RP; Scheen AJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
    [No Abstract]   [Full Text] [Related]  

  • 11. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 12. Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.
    Ioannidis JPA
    JAMA; 2017 Aug; 318(5):419-420. PubMed ID: 28738115
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins and the soul of medicine.
    Ornish D
    Am J Cardiol; 2002 Jun; 89(11):1286-90. PubMed ID: 12031729
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
    Athyros VG; Tziomalos K; Karagiannis A; Wierzbicki AS; Mikhailidis DP
    Curr Opin Cardiol; 2010 Jul; 25(4):406-10. PubMed ID: 20375883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-of-the-art update and review: clinical trials of lipid-lowering agents.
    Kwiterovich PO
    Am J Cardiol; 1998 Dec; 82(12A):3U-17U; discussion 39U-41U. PubMed ID: 9915657
    [No Abstract]   [Full Text] [Related]  

  • 18. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
    Hurley DL; Isley WL
    Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
    [No Abstract]   [Full Text] [Related]  

  • 19. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration therapy in hypercholesterolemia: a novel approach to achieving lipid goals--introduction.
    Chilton RJ
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S3-4. PubMed ID: 15467016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.